Get Started

DRTX

(MM) (DRTX)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DRTX

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Date	Time	Source	Headline	Symbol	Company
10/06/2014	4:54PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
10/06/2014	4:36PM	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:DRTX	(MM)
10/06/2014	1:22PM	Business Wire	Glancy Binkow & Goldberg LLP is Investigating Durata Therapeutics, Inc. Board of Directors	NASDAQ:DRTX	(MM)
10/06/2014	12:03PM	Business Wire	INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Durata Therapeutics Inc. Concerning...	NASDAQ:DRTX	(MM)
10/06/2014	11:51AM	Business Wire	DURATA THERAPEUTICS SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Acquisition by Acta...	NASDAQ:DRTX	(MM)
10/06/2014	11:35AM	Business Wire	EQUITY ALERT: Rosen Law Firm Announces Investigation of Durata Therapeutics, Inc. Concerning its Proposed Sale to Actavis plc...	NASDAQ:DRTX	(MM)
10/06/2014	11:34AM	PR Newswire (US)	DURATA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	NASDAQ:DRTX	(MM)
10/06/2014	9:32AM	Business Wire	DURATA SHAREHOLDER ALERT: Johnson & Weaver, LLP Launches an Investigation into the Proposed Sale of Durata Therapeutics, Inc....	NASDAQ:DRTX	(MM)
10/06/2014	8:00AM	PR Newswire (US)	Actavis to Acquire Durata Therapeutics, Inc.	NASDAQ:DRTX	(MM)
09/30/2014	3:08PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:DRTX	(MM)
08/28/2014	1:23PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
08/28/2014	1:20PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:DRTX	(MM)
08/28/2014	1:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
08/28/2014	1:13PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:DRTX	(MM)
08/28/2014	9:09AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
08/28/2014	9:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
08/22/2014	5:01PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
08/07/2014	7:31AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DRTX	(MM)
08/07/2014	7:21AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
08/01/2014	10:36AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
07/31/2014	8:30AM	GlobeNewswire Inc.	Durata Therapeutics to Report Second Quarter 2014 Financial Results on August 7, 2014	NASDAQ:DRTX	(MM)
07/30/2014	8:30AM	GlobeNewswire Inc.	Durata Therapeutics Enters Into an Exclusive License and Supply Agreement With Angelini to Commercialize Dalbavancin in Certa...	NASDAQ:DRTX	(MM)
07/18/2014	8:00AM	GlobeNewswire Inc.	Durata Therapeutics Announces the U.S. Launch of DALVANCE(TM)	NASDAQ:DRTX	(MM)
06/17/2014	9:00AM	GlobeNewswire Inc.	Durata Therapeutics to Present at Upcoming Investor Conferences	NASDAQ:DRTX	(MM)
06/13/2014	1:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
06/04/2014	5:00PM	GlobeNewswire Inc.	New England Journal of Medicine Publishes Data From Durata Therapeutics' Discover Program	NASDAQ:DRTX	(MM)
06/02/2014	4:14PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
05/28/2014	12:47PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DRTX	(MM)
05/23/2014	6:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
05/23/2014	5:51PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)